Royal Prince Alfred Hospital

Recent data suggests even slightly higher than that across Australia for diabetes related foot disease.

And in our diabetes centre at Royal Prince Alfred Hospital, those with the history of foot ulceration have much lesser longevity, higher mortality rates than those in the diabetes centre who haven't had such a history, probably due to related cardiovascular, ultimately, disease

that leads to demise.

Well, we need to integrate care in people with diabetes.

Leading our discussion today is dermatologist Professor Pascal Guterra.

Pascal is the director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital, a professorial research fellow at the University of Sydney, and a faculty member of Melanoma Institute Australia.

We're joined in the studio today by Professor Rachel Morton, Director of Health Economics and Health Technology Assessment at Sydney Clinical Trial Centre, the University of Sydney, and a Melanoma Institute Australia faculty member.

We're also delighted to have Professor Victoria Marr and Dr Amelia Smith joining us virtually.

What have we learned so far about communicating this personalized risk to patients?

So this is one of the areas I'm really most interested in because generating the risk estimate is really half the challenge and the other half is helping people to understand that risk estimate.

So I think one informative example comes from the tailored surveillance project, which we run at Melanoma Institute Australia and Royal Prince Alfred Hospital.

So this project looked at whether personal melanoma risk assessment and tailored surveillance recommendations could be integrated into routine dermatology care.

Dad, while at times was scared and uncertain, he knew to his very last breath the truth of the gospel and the faithfulness of God in all things, even in leukemia.

The nurses and doctors at RPA Hospital even commented on how different the ward was when he was there.

The gospel made all the difference to who Dad was and how he approached everything.

It sounds

I'm a, an ano-anatomical pathologist working at Peter Mac.

So Peter Mac has, uh, got a very active clinical and pathology unit in melanoma, and I've had research and, um, and, uh, consultation work background working as a fellow, uh, with Richard Scolyer at Royal Prince Alfred Hospital.

So that's what my back-background I bring to the melanoma space.

Thank you.

Rob.

Well, I'm also an anatomical pathologist, uh, with a special interest in melanoma.

I'm based at the Royal Prince Alfred Hospital in Sydney and a faculty member of the Melanoma Institute of Australia.

I've had the distinct joy of working with both Louise, we were both fellows together back in twenty sixteen, and Danielle was our fellow a couple of years ago, and I helped sort of supervise her through her fellowship at RPA.

For those of you who don't know me, my name is Sam Hocking.

I'm a clinical academic at the University of Sydney and an endocrinologist at Royal Prince Alfred Hospital, where I principally work in the management of obesity.

I'm also a member of ANZOS Council and I'm the current president of the National Association of Clinical Obesity Services.

So NACOSS was founded some time ago to improve evidence-based management of obesity and to make sure this is delivered in a stigma-free manner.

From 1903 to 1913, Chapman was a lecturer and a demonstrator in physiology at the University of Sydney and was awarded the David Syme Research Prize by the University of Melbourne in 1910.

In 1907, he was appointed Honorary Pathological Chemist at the Royal Prince Alfred Hospital.

At some point, they moved to the Blue Mountains to a house that they called Hiawatha in Blackheath.

Chapman still found time for an active role in the community of Blackheath.

Evidence will be given at the inquest, however, that filed away by the Senator certain charges which suggest Professor Chapman made indirect profits by recommending the purchase of inferior or higher priced equipment from certain firms.

And on the 19th of June 1934 in the Adelaide News, from Sydney.

The story of dramatic efforts to save the life of Professor Henry George Chapman, Director of Cancer Research, who was found unconscious in his room at the Cancer Research Branch of the Sydney University on the 25th of May, was told by Dr Alan Lilly, Medical Superintendent of Royal Prince Alfred Hospital, to the coroner at the inquest today.

At 7.45pm on the day of Chapman's admission to hospital, the patient's condition indicated a possibility of his being under the influence of a narcotic poison.